Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Male breast cancer.
Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A. Ottini L, et al. Among authors: rizzo s. Crit Rev Oncol Hematol. 2010 Feb;73(2):141-55. doi: 10.1016/j.critrevonc.2009.04.003. Epub 2009 May 7. Crit Rev Oncol Hematol. 2010. PMID: 19427229 Review.
HER2-positive male breast cancer: an update.
Ottini L, Capalbo C, Rizzolo P, Silvestri V, Bronte G, Rizzo S, Russo A. Ottini L, et al. Among authors: rizzo s. Breast Cancer (Dove Med Press). 2010 Oct 4;2:45-58. doi: 10.2147/BCTT.S6519. Breast Cancer (Dove Med Press). 2010. PMID: 24367166 Free PMC article. Review.
Hereditary ovarian cancer.
Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G. Russo A, et al. Among authors: rizzo s. Crit Rev Oncol Hematol. 2009 Jan;69(1):28-44. doi: 10.1016/j.critrevonc.2008.06.003. Epub 2008 Jul 24. Crit Rev Oncol Hematol. 2009. PMID: 18656380 Free article. Review.
A headlight on liquid biopsies: a challenging tool for breast cancer management.
Massihnia D, Perez A, Bazan V, Bronte G, Castiglia M, Fanale D, Barraco N, Cangemi A, Di Piazza F, Calò V, Rizzo S, Cicero G, Pantuso G, Russo A. Massihnia D, et al. Among authors: rizzo s. Tumour Biol. 2016 Apr;37(4):4263-73. doi: 10.1007/s13277-016-4856-x. Epub 2016 Jan 20. Tumour Biol. 2016. PMID: 26790442 Review.
EGFR inhibition in NSCLC: New findings…. and opened questions?
Passiglia F, Listì A, Castiglia M, Perez A, Rizzo S, Bazan V, Russo A. Passiglia F, et al. Among authors: rizzo s. Crit Rev Oncol Hematol. 2017 Apr;112:126-135. doi: 10.1016/j.critrevonc.2017.02.009. Epub 2017 Feb 16. Crit Rev Oncol Hematol. 2017. PMID: 28325254 Free article. Review.
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials.
Rizzo S, Galvano A, Pantano F, Iuliani M, Vincenzi B, Passiglia F, Spoto S, Tonini G, Bazan V, Russo A, Santini D. Rizzo S, et al. Crit Rev Oncol Hematol. 2017 Dec;120:227-233. doi: 10.1016/j.critrevonc.2017.09.008. Epub 2017 Oct 16. Crit Rev Oncol Hematol. 2017. PMID: 29110971 Review.
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials.
Santini D, Galvano A, Pantano F, Incorvaia L, Rizzo S, Vincenzi B, Castellana L, Giuliana G, Guadagni F, Toia F, Tonini G, Russo A, Badalamenti G, Bazan V. Santini D, et al. Among authors: rizzo s. Crit Rev Oncol Hematol. 2019 Oct;142:68-75. doi: 10.1016/j.critrevonc.2019.07.013. Epub 2019 Jul 25. Crit Rev Oncol Hematol. 2019. PMID: 31377434
1,287 results